this paper is to analyze federal antitrust enforcers are investigating whether a multinational pharmaceutical company has attempted to minimize the impact of generic competition to one of its most profitable prescription drugs. This anti-depressant drug is the company’s best seller‚ with sales last year of $2.11 billion‚ representing a 22% increase from the year before. I will review whether pharmaceutical companies have engaged in activities that will prevent generic brands to the prescription drug
Premium Pharmacology Generic drug Food and Drug Administration
CONTROLLED DRUG Prescription i. Check the details on the prescription (same form for both NHS and private) Prescriber : Signature‚ name‚ address (check the signature) Patient : Surname‚ Forename address of the‚ age is not require Drug : Name‚ form(verify if diff from PMR)‚ strength‚ dose (must detail eg: one as directed not as directed‚ one prn not prn)‚ quantity (check if it is excessive or not) -both in number and wording ex: 100 (one hundred) can change this by yourself no need to ask the
Premium Pharmacology
INTRODUCTION 1.1 OVERVIEW: Trade Related Aspects of Intellectual property Rights was put into effect in the developed countries since Jan 1996. And it will be implemented in Less Developed Countries starting from Jan 2006. Egypt is preparing its pharmaceutical industry for such agreement. A sense of optimism is expressed in the rich North. While a sense of pessimism is expressed in the poor South. Research and Development companies feel quite secure. Reverse Engineering companies (producing imitated
Premium Patent
PHARMACEUTICAL PATENTING IN INDIA:PROBLEM OF PUBLIC ACCESS TO HEALTH TABLE OF CASES 1) Novartis AG v. Union of India‚ (2007) 4 MLJ 1153 2) Bayer Corporation & Others v. Cipla‚ UOI & others‚ 2009(41) PTC 643 (Del). INTRODUCTION A pharmaceutical drug‚ also referred to as medicine‚ is a chemical substance used in the medication or in the preparation of medication for treatment‚ cure‚ prevention or diagnosis of disease. The definition of the term drug includes articles intended for use in
Premium Patent
RESEARCH AND DEVELOPMENT SCENARIO IN INDIAN PHARMACEUTICAL COMPANIES SUBMITED BY: MR. SHAMSHAD AH DEPARTMENT OF PHARMACEUTICAL MANAGEMENT DEPARTMENT OF PHARMACEUTICAL MANAGEMENT NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH SEC. NO. 67‚ S.A.S. NAGAR MOHLI PUNJAB CONTENTS: * OBJECTIVES....................................................................................3 * INTRODUCTION.............................................................................3
Premium Pharmaceutical industry Clinical trial Drug discovery
The Global Pharmaceutical Industry: Swallowing a Bitter Pill The case describes the evolution of the pharmaceutical industry and its strategic environment. Attention is drawn to environmental pressures from regulators and payers. Key forces driving the industry are discussed‚ including addressing unmet medical needs‚ the importance of innovation and time to market‚ and globalisation. The case illustrates how an increasingly hostile environment‚ combined with a decline in R&D productivity‚ led
Premium Medicine Pharmacology Industry
of Pharmaceutical Company in Bangladesh Faruk Hossan Md Ahsan Habib Supervisor: José Ferraz Nunes Examiner: Bengt Kjellén Master‟s thesis in international Business 15 ECTS Department of Economic and Informatics University West Spring term 2010 0 ABSTRACT The thesis applies performance evaluation of pharmaceutical company in Bangladesh. It means evaluate how well the company performs. The main aim is achieved through ratio analysis of two pharmaceutical (Beximco and Square pharmaceutical) companies
Premium Financial ratios Generally Accepted Accounting Principles Balance sheet
References: 1. Essentials of financial accounting By Kermit D. Larson 2. Square Pharmaceuticals Ltd. a. Annual Report 2008-2009 b. Annual Report 2008-2009 c. Annual Report 2008-2009 3. http://www.investopedia.com 4. http://accountingexplained.com 5. http://www.squarepharma.com.bd
Premium Balance sheet Generally Accepted Accounting Principles Financial ratio
Domestic drug manufacturers have cast their eyes overseas for growth and four of them have received the certificate of pharmaceutical product (CPP)‚ one of the pre-requisites for obtaining an export licence from the Department of Drug Administration (DDA). According to the DDA‚ Lomus Pharmaceuticals‚ Deurali-Janata Pharmaceuticals‚ Elder Pharmaceuticals and National Health Care Nepal have received the CPP. The CPP is a must for drug manufacturers wanting to export their products. Once the CPP has
Premium Pharmacology Pharmaceutical drug Drug
Background Information: The case is about the dilemma of a product manager of a pharmaceutical company‚ regarding the name of a new product that has failed to capture the market as expected. The case talks about brand extension of an existing brand which has a strong customer base in the field of neurology. It is named after the core brand so that it could enjoy a good brand recall. After completing the market research‚ the teaser campaign is started to attract the target segment i.e. gynecologists
Premium Marketing Neurology Pharmacology